Monogram Orthopaedics Inc. Common Stock Total Assets
Monogram Orthopaedics Inc. Common Stock total assets. Based on the latest financial reports, Monogram Orthopaedics Inc. Common Stock (MGRM) holds total assets worth $15.00 Million USD as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Monogram Orthopaedics Inc. Common Stock (MGRM) total market value for the company's overall valuation and market capitalisation.
Total Assets of Monogram Orthopaedics Inc. Common Stock (2017–2024)
Total assets of Monogram Orthopaedics Inc. Common Stock from 2017 to 2024. This chart illustrates how Monogram Orthopaedics Inc. Common Stock's total assets have evolved over time, based on quarterly financial data. See MGRM live share price for real-time trading data and today's change.
Monogram Orthopaedics Inc. Common Stock - Asset Composition Analysis
Monogram Orthopaedics Inc. Common Stock Total Assets Breakdown (December 2024)
Monogram Orthopaedics Inc. Common Stock total assets breakdown as of December 2024. Monogram Orthopaedics Inc. Common Stock's total assets of $15.00 Million consist of 91.6% current assets and 8.4% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 88.1% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $288.00K | 1.6% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $339.00K | 1.9% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2017–2024)
This chart illustrates how Monogram Orthopaedics Inc. Common Stock's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital to net assets of Monogram Orthopaedics Inc. Common Stock to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Monogram Orthopaedics Inc. Common Stock's current assets represent 91.6% of total assets in 2024, an increase from 63.1% in 2017.
- Cash Position: Cash and equivalents constituted 88.1% of total assets in 2024, up from 63.1% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2017.
- Asset Diversification: The largest asset category is intangible assets at 1.9% of total assets.
Monogram Orthopaedics Inc. Common Stock Competitors by Total Assets
Key competitors of Monogram Orthopaedics Inc. Common Stock based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
BMC Medical Co. Ltd. A
SHE:301367
|
China | CN¥3.59 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Hironic Co. Ltd
KQ:149980
|
Korea | ₩80.01 Billion |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
Monogram Orthopaedics Inc. Common Stock - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.16 | 3.28 | 5.76 |
| Quick Ratio | 2.11 | 3.16 | 5.76 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $7.23 Million | $5.64 Million | $7.93 Million |
Monogram Orthopaedics Inc. Common Stock - Advanced Valuation Insights
This section examines the relationship between Monogram Orthopaedics Inc. Common Stock's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 27.98 |
| Latest Market Cap to Assets Ratio | 13.72 |
| Asset Growth Rate (YoY) | 7.2% |
| Total Assets | $17.77 Million |
| Market Capitalization | $243.79 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Monogram Orthopaedics Inc. Common Stock's assets at a significant premium (13.72x), suggesting investors see substantial growth potential or unique competitive advantages.
Positive Asset Growth: Monogram Orthopaedics Inc. Common Stock's assets grew by 7.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Monogram Orthopaedics Inc. Common Stock (2017–2024)
The table below shows the annual total assets of Monogram Orthopaedics Inc. Common Stock from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $17.77 Million | +7.18% |
| 2023-12-31 | $16.58 Million | +21.10% |
| 2022-12-31 | $13.69 Million | +57.08% |
| 2021-12-31 | $8.72 Million | +7.39% |
| 2020-12-31 | $8.12 Million | +209.75% |
| 2019-12-31 | $2.62 Million | +121.25% |
| 2018-12-31 | $1.18 Million | +216.58% |
| 2017-12-31 | $374.08K | -- |
About Monogram Orthopaedics Inc. Common Stock
As of October 7, 2025, Monogram Technologies Inc. was acquired by Zimmer Biomet Holdings, Inc.. Monogram Technologies Inc. engages in developing surgical robot to enable placement of patient optimized orthopedic implants in the United States. It intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and ot… Read more